Predicting Chronic Kidney Disease Progression

Patent №

US 11,627,917

Granted

2023-04-18

Filed 2019

Owner

CERNER INNOVATION, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16731595

Systems, methods, and computer-readable media are provided for identification of patients having an elevated near-term risk of chronic kidney disease progression, including quantitatively predicting whether or not an elevated risk of progression of Stage 3 or Stage 4 chronic kidney disease is likely within a time interval of up to 36 months subsequent to computing the prediction. Based on the prediction, appropriate care providers may be notified so that the risk of CKD progression may be mitigated. In some embodiments, serial measurements are obtained of urine osmolality, and a challenge with an AVP V2 antagonist and serum sodium concentration is provided. From a time series based on the serial measurements, estimates of each variable's velocity and/or doubling-time may be determined. These values then may be combined via a multivariable mathematical model for providing a leading indicator of near-term future abnormalities in kidney function.

PlanningA61B 5/7275A61B 5/14546A61B 5/201A61B 5/4836A61B 5/4842A61B 5/4884A61B 5/7203A61B 5/7264

AI classification

Planning0.98
AI hardware0.14
Machine learning0.06
Natural language0.00
Vision0.00
Knowledge representation0.00
Evolutionary computation0.00
Speech0.00

Ownership

CERNER INNOVATION, INC.

assignment · 514800438

Assignors

MCNAIR, DOUGLAS S

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC